Ranking Profile - Nanjing King-friend Biochemical Pharmaceutical Co Ltd

Introduction

Nanjing King-friend Biochemical Pharmaceutical Co Ltd (NKF) manufactures and distributes biochemical pharmaceuticals. The company produces raw materials including heparin sodium to prevent clots, thromboembolic diseases, and diffuse intravascular coagulation. It offers preparation products such as enoxaparin sodium, dalteparin sodium and sodium heparin calcium in the form of an injection to treat venous thrombosis. The company also exports its products to European and American countries. NKF is headquartered in Nanjing, Jiangsu, China.

Company info

Country (HQ): China
Sector: Pharmaceuticals and Healthcare
Market Cap (US$ m): 3,333
Revenue (US$ m): 552 (2022)

Innovation ranking

337

Innovation score

Closest peers in the Pharmaceuticals and Healthcare sector

Innovation Ranking

Company
Headquarters
Sector

Johnson & Johnson

United States

Pharmaceuticals and Healthcare

F. Hoffmann-La Roche Ltd

Switzerland

Pharmaceuticals and Healthcare

Nanjing King-friend Biochemical Pharmaceutical Co Ltd

China

Pharmaceuticals and Healthcare

EyeGate Pharmaceuticals Inc

United States

Pharmaceuticals and Healthcare

Shin Poong Pharm Co Ltd

South Korea

Pharmaceuticals and Healthcare

Are you ranked? Get the Innovation Ranking Report

  • Company Ranking Report
    • If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
    • Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
    • Contextualised information on the company's standing in relation to peers
    • Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
    • Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
  • Rosettes
  • Certificate of Achievement
  • Press release
Screenshot of Deal Makers